IL100799A - תכשירים המכילים מטריצה הניתנת לפירוק ביולוגי לטיפול או תיקון של חסחוס - Google Patents

Info

Publication number

IL100799A

IL100799A IL10079992A IL10079992A IL100799A IL 100799 A IL100799 A IL 100799A IL 10079992 A IL10079992 A IL 10079992A IL 10079992 A IL10079992 A IL 10079992A IL 100799 A IL100799 A IL 100799A

Authority

IL

Israel

Prior art keywords

matrix

tgf

cartilage

defect

repair

Prior art date

1991-01-31

Links

• Espacenet
• Global Dossier
• Discuss

• 239000011159 matrix material Substances 0.000 title claims abstract description 156
• 230000008439 repair process Effects 0.000 title claims abstract description 103
• 210000000845 cartilage Anatomy 0.000 title claims abstract description 85
• 239000000203 mixture Substances 0.000 title claims abstract description 65
• 238000011282 treatment Methods 0.000 title claims abstract description 30
• 230000007547 defect Effects 0.000 claims abstract description 171
• 210000004027 cell Anatomy 0.000 claims abstract description 93
• 230000001131 transforming effect Effects 0.000 claims abstract description 57
• 230000035755 proliferation Effects 0.000 claims abstract description 51
• 230000003399 chemotactic effect Effects 0.000 claims abstract description 37
• 108010067787 Proteoglycans Proteins 0.000 claims abstract description 35
• 102000016611 Proteoglycans Human genes 0.000 claims abstract description 35
• 210000001612 chondrocyte Anatomy 0.000 claims abstract description 26
• 230000003902 lesion Effects 0.000 claims abstract description 25
• 239000003795 chemical substances by application Substances 0.000 claims description 60
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 56
• 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 55
• 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 55
• 108010049003 Fibrinogen Proteins 0.000 claims description 35
• 102000008946 Fibrinogen Human genes 0.000 claims description 35
• 229940012952 fibrinogen Drugs 0.000 claims description 35
• 239000003102 growth factor Substances 0.000 claims description 26
• 108010073385 Fibrin Proteins 0.000 claims description 25
• 102000009123 Fibrin Human genes 0.000 claims description 25
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims description 25
• 229950003499 fibrin Drugs 0.000 claims description 25
• 108090000190 Thrombin Proteins 0.000 claims description 20
• 229960004072 thrombin Drugs 0.000 claims description 20
• 102000008186 Collagen Human genes 0.000 claims description 18
• 108010035532 Collagen Proteins 0.000 claims description 18
• 229920001436 collagen Polymers 0.000 claims description 17
• 239000000463 material Substances 0.000 claims description 17
• 239000002502 liposome Substances 0.000 claims description 16
• 101150021185 FGF gene Proteins 0.000 claims description 9
• 229920002684 Sepharose Polymers 0.000 claims description 9
• 230000001737 promoting effect Effects 0.000 claims description 8
• 230000021164 cell adhesion Effects 0.000 claims description 5
• 239000007857 degradation product Substances 0.000 claims description 5
• 239000000835 fiber Substances 0.000 claims description 5
• IYMAXBFPHPZYIK-BQBZGAKWSA-N Arg-Gly-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O IYMAXBFPHPZYIK-BQBZGAKWSA-N 0.000 claims description 4
• 108010072041 arginyl-glycyl-aspartic acid Proteins 0.000 claims description 4
• 229920013641 bioerodible polymer Polymers 0.000 claims description 4
• 238000004519 manufacturing process Methods 0.000 claims description 4
• 108010010803 Gelatin Proteins 0.000 claims description 3
• 102000002265 Human Growth Hormone Human genes 0.000 claims description 3
• 108010000521 Human Growth Hormone Proteins 0.000 claims description 3
• 239000000854 Human Growth Hormone Substances 0.000 claims description 3
• 150000001720 carbohydrates Chemical class 0.000 claims description 3
• 239000003814 drug Substances 0.000 claims description 3
• 239000008273 gelatin Substances 0.000 claims description 3
• 229920000159 gelatin Polymers 0.000 claims description 3
• 235000019322 gelatine Nutrition 0.000 claims description 3
• 235000011852 gelatine desserts Nutrition 0.000 claims description 3
• 229920002971 Heparan sulfate Polymers 0.000 claims description 2
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
• -1 PDGF Proteins 0.000 claims description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 2
• 230000002607 hemopoietic effect Effects 0.000 claims description 2
• 108090000542 Lymphotoxin-alpha Proteins 0.000 claims 1
• 102000004083 Lymphotoxin-alpha Human genes 0.000 claims 1
• 102100040247 Tumor necrosis factor Human genes 0.000 claims 1
• 238000000034 method Methods 0.000 abstract description 41
• 102000004190 Enzymes Human genes 0.000 abstract description 32
• 108090000790 Enzymes Proteins 0.000 abstract description 32
• 238000011049 filling Methods 0.000 abstract description 12
• 241001465754 Metazoa Species 0.000 abstract description 7
• 239000011148 porous material Substances 0.000 abstract description 5
• 230000022159 cartilage development Effects 0.000 abstract description 2
• 238000002355 open surgical procedure Methods 0.000 abstract description 2
• 239000000243 solution Substances 0.000 description 63
• 229940088598 enzyme Drugs 0.000 description 31
• 230000000694 effects Effects 0.000 description 19
• 108090000765 processed proteins & peptides Proteins 0.000 description 18
• 150000001875 compounds Chemical class 0.000 description 17
• 210000001519 tissue Anatomy 0.000 description 17
• 210000001188 articular cartilage Anatomy 0.000 description 15
• 210000000988 bone and bone Anatomy 0.000 description 14
• 102000004196 processed proteins & peptides Human genes 0.000 description 14
• 241000283973 Oryctolagus cuniculus Species 0.000 description 12
• 201000008482 osteoarthritis Diseases 0.000 description 12
• 230000009466 transformation Effects 0.000 description 12
• 102000037716 Chondroitin-sulfate-ABC endolyases Human genes 0.000 description 10
• 108090000819 Chondroitin-sulfate-ABC endolyases Proteins 0.000 description 10
• 238000003556 assay Methods 0.000 description 10
• 238000002474 experimental method Methods 0.000 description 9
• 238000006116 polymerization reaction Methods 0.000 description 9
• 239000000126 substance Substances 0.000 description 9
• 230000004663 cell proliferation Effects 0.000 description 8
• 230000002297 mitogenic effect Effects 0.000 description 8
• 239000012062 aqueous buffer Substances 0.000 description 7
• 229920001184 polypeptide Polymers 0.000 description 7
• 230000002062 proliferating effect Effects 0.000 description 7
• 230000004936 stimulating effect Effects 0.000 description 7
• 102000000503 Collagen Type II Human genes 0.000 description 6
• 108010041390 Collagen Type II Proteins 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 238000000338 in vitro Methods 0.000 description 6
• 208000014674 injury Diseases 0.000 description 6
• 210000000629 knee joint Anatomy 0.000 description 6
• 102000004169 proteins and genes Human genes 0.000 description 6
• 108090000623 proteins and genes Proteins 0.000 description 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
• 230000006378 damage Effects 0.000 description 5
• 230000004069 differentiation Effects 0.000 description 5
• 230000029087 digestion Effects 0.000 description 5
• 210000003035 hyaline cartilage Anatomy 0.000 description 5
• 230000006698 induction Effects 0.000 description 5
• 230000000379 polymerizing effect Effects 0.000 description 5
• 210000005065 subchondral bone plate Anatomy 0.000 description 5
• 238000001356 surgical procedure Methods 0.000 description 5
• 208000032843 Hemorrhage Diseases 0.000 description 4
• 102000055008 Matrilin Proteins Human genes 0.000 description 4
• 108010072582 Matrilin Proteins Proteins 0.000 description 4
• 241000906034 Orthops Species 0.000 description 4
• 108060008539 Transglutaminase Proteins 0.000 description 4
• 230000000740 bleeding effect Effects 0.000 description 4
• 230000015556 catabolic process Effects 0.000 description 4
• 238000006731 degradation reaction Methods 0.000 description 4
• 230000012010 growth Effects 0.000 description 4
• 239000007924 injection Substances 0.000 description 4
• 238000002347 injection Methods 0.000 description 4
• 230000004044 response Effects 0.000 description 4
• 239000011780 sodium chloride Substances 0.000 description 4
• 102000003601 transglutaminase Human genes 0.000 description 4
• 230000008733 trauma Effects 0.000 description 4
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 4
• 229920001817 Agar Polymers 0.000 description 3
• 102400001368 Epidermal growth factor Human genes 0.000 description 3
• 101800003838 Epidermal growth factor Proteins 0.000 description 3
• 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 3
• 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 3
• 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 3
• 102100037852 Insulin-like growth factor I Human genes 0.000 description 3
• 239000004365 Protease Substances 0.000 description 3
• 102000009618 Transforming Growth Factors Human genes 0.000 description 3
• 108010009583 Transforming Growth Factors Proteins 0.000 description 3
• 108090000631 Trypsin Proteins 0.000 description 3
• 102000004142 Trypsin Human genes 0.000 description 3
• 239000008272 agar Substances 0.000 description 3
• 230000032823 cell division Effects 0.000 description 3
• 230000012292 cell migration Effects 0.000 description 3
• 230000035605 chemotaxis Effects 0.000 description 3
• 229940116977 epidermal growth factor Drugs 0.000 description 3
• 238000000099 in vitro assay Methods 0.000 description 3
• 210000003127 knee Anatomy 0.000 description 3
• 230000033001 locomotion Effects 0.000 description 3
• 244000309715 mini pig Species 0.000 description 3
• 230000003204 osmotic effect Effects 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 241000894007 species Species 0.000 description 3
• 230000000638 stimulation Effects 0.000 description 3
• 239000012588 trypsin Substances 0.000 description 3
• FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
• 108090000056 Complement factor B Proteins 0.000 description 2
• 102000003712 Complement factor B Human genes 0.000 description 2
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
• 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
• 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
• 102000016359 Fibronectins Human genes 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 229920002683 Glycosaminoglycan Polymers 0.000 description 2
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
• 102000000646 Interleukin-3 Human genes 0.000 description 2
• 108010002386 Interleukin-3 Proteins 0.000 description 2
• 206010023215 Joint effusion Diseases 0.000 description 2
• 108091005804 Peptidases Proteins 0.000 description 2
• 102000035195 Peptidases Human genes 0.000 description 2
• 208000027418 Wounds and injury Diseases 0.000 description 2
• 239000002250 absorbent Substances 0.000 description 2
• 230000002745 absorbent Effects 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 230000002378 acidificating effect Effects 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 239000008280 blood Substances 0.000 description 2
• 210000004369 blood Anatomy 0.000 description 2
• 230000010261 cell growth Effects 0.000 description 2
• 238000006243 chemical reaction Methods 0.000 description 2
• 239000002131 composite material Substances 0.000 description 2
• 210000002808 connective tissue Anatomy 0.000 description 2
• 238000005520 cutting process Methods 0.000 description 2
• 201000010099 disease Diseases 0.000 description 2
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
• 210000002950 fibroblast Anatomy 0.000 description 2
• 230000035876 healing Effects 0.000 description 2
• 238000010562 histological examination Methods 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 238000001802 infusion Methods 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 230000008407 joint function Effects 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• 238000002156 mixing Methods 0.000 description 2
• 230000008520 organization Effects 0.000 description 2
• 238000002271 resection Methods 0.000 description 2
• IHQKEDIOMGYHEB-UHFFFAOYSA-M sodium dimethylarsinate Chemical compound [Na+].C[As](C)([O-])=O IHQKEDIOMGYHEB-UHFFFAOYSA-M 0.000 description 2
• 210000001258 synovial membrane Anatomy 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 230000002792 vascular Effects 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• 102000009027 Albumins Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 208000010392 Bone Fractures Diseases 0.000 description 1
• 206010007710 Cartilage injury Diseases 0.000 description 1
• 241000819038 Chichester Species 0.000 description 1
• 101710106625 Chondroitinase-AC Proteins 0.000 description 1
• 206010061762 Chondropathy Diseases 0.000 description 1
• 108090000317 Chymotrypsin Proteins 0.000 description 1
• 241000557626 Corvus corax Species 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
• 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
• 108010071289 Factor XIII Proteins 0.000 description 1
• 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 1
• 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 1
• 108010051815 Glutamyl endopeptidase Proteins 0.000 description 1
• 108010003272 Hyaluronate lyase Proteins 0.000 description 1
• 102000001974 Hyaluronidases Human genes 0.000 description 1
• 208000026350 Inborn Genetic disease Diseases 0.000 description 1
• 102000000422 Matrix Metalloproteinase 3 Human genes 0.000 description 1
• 208000024556 Mendelian disease Diseases 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
• 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
• 108010059712 Pronase Proteins 0.000 description 1
• KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
• 102000013275 Somatomedins Human genes 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
• 239000008351 acetate buffer Substances 0.000 description 1
• 210000000142 acromioclavicular joint Anatomy 0.000 description 1
• 230000001464 adherent effect Effects 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 150000001413 amino acids Chemical group 0.000 description 1
• 239000002269 analeptic agent Substances 0.000 description 1
• 229940035676 analgesics Drugs 0.000 description 1
• 238000004458 analytical method Methods 0.000 description 1
• 210000003484 anatomy Anatomy 0.000 description 1
• 239000000730 antalgic agent Substances 0.000 description 1
• 239000002260 anti-inflammatory agent Substances 0.000 description 1
• 229940121363 anti-inflammatory agent Drugs 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 229960002319 barbital Drugs 0.000 description 1
• 239000011324 bead Substances 0.000 description 1
• HOQPTLCRWVZIQZ-UHFFFAOYSA-H bis[[2-(5-hydroxy-4,7-dioxo-1,3,2$l^{2}-dioxaplumbepan-5-yl)acetyl]oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HOQPTLCRWVZIQZ-UHFFFAOYSA-H 0.000 description 1
• 229960000182 blood factors Drugs 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 230000003139 buffering effect Effects 0.000 description 1
• 230000034196 cell chemotaxis Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 239000003042 chondroprotective agent Substances 0.000 description 1
• 229960002376 chymotrypsin Drugs 0.000 description 1
• 239000000515 collagen sponge Substances 0.000 description 1
• 230000002301 combined effect Effects 0.000 description 1
• 230000009514 concussion Effects 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• 210000000399 corneal endothelial cell Anatomy 0.000 description 1
• 238000004132 cross linking Methods 0.000 description 1
• 230000000593 degrading effect Effects 0.000 description 1
• 238000006073 displacement reaction Methods 0.000 description 1
• 238000005553 drilling Methods 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 230000007613 environmental effect Effects 0.000 description 1
• 230000006862 enzymatic digestion Effects 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 238000001976 enzyme digestion Methods 0.000 description 1
• 210000002744 extracellular matrix Anatomy 0.000 description 1
• 229940126864 fibroblast growth factor Drugs 0.000 description 1
• 210000000968 fibrocartilage Anatomy 0.000 description 1
• 239000005338 frosted glass Substances 0.000 description 1
• 230000006870 function Effects 0.000 description 1
• 239000000499 gel Substances 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
• 239000004312 hexamethylene tetramine Substances 0.000 description 1
• VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
• 210000004276 hyalin Anatomy 0.000 description 1
• 229960002773 hyaluronidase Drugs 0.000 description 1
• 238000002513 implantation Methods 0.000 description 1
• 238000011065 in-situ storage Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 229940076264 interleukin-3 Drugs 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 210000000281 joint capsule Anatomy 0.000 description 1
• 210000003734 kidney Anatomy 0.000 description 1
• 210000003041 ligament Anatomy 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 239000006193 liquid solution Substances 0.000 description 1
• 210000004324 lymphatic system Anatomy 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 238000002595 magnetic resonance imaging Methods 0.000 description 1
• 230000005499 meniscus Effects 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 210000003098 myoblast Anatomy 0.000 description 1
• 210000004498 neuroglial cell Anatomy 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
• 239000012285 osmium tetroxide Substances 0.000 description 1
• 210000000963 osteoblast Anatomy 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 239000002504 physiological saline solution Substances 0.000 description 1
• 239000002243 precursor Substances 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 238000011555 rabbit model Methods 0.000 description 1
• 230000008929 regeneration Effects 0.000 description 1
• 238000011069 regeneration method Methods 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000008458 response to injury Effects 0.000 description 1
• 229910052707 ruthenium Inorganic materials 0.000 description 1
• 238000007790 scraping Methods 0.000 description 1
• 210000001044 sensory neuron Anatomy 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
• 210000004872 soft tissue Anatomy 0.000 description 1
• 208000035736 spondylodysplastic type Ehlers-Danlos syndrome Diseases 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008174 sterile solution Substances 0.000 description 1
• 210000001898 sternoclavicular joint Anatomy 0.000 description 1
• 108091007196 stromelysin Proteins 0.000 description 1
• 210000001179 synovial fluid Anatomy 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 210000001738 temporomandibular joint Anatomy 0.000 description 1
• 230000006032 tissue transformation Effects 0.000 description 1
• 238000003325 tomography Methods 0.000 description 1
• 230000000472 traumatic effect Effects 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 229960001322 trypsin Drugs 0.000 description 1
• 102000003390 tumor necrosis factor Human genes 0.000 description 1
• 210000003556 vascular endothelial cell Anatomy 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 210000003857 wrist joint Anatomy 0.000 description 1